The generic versions of semaglutide are expected to be at least 50% cheaper— ₹5,000 for a weekly dose—than Ozempic in India .

The upcoming patent expiry for Ozempic in India is set to dramatically lower the cost of semaglutide, making this once-premium diabetes and weight-loss drug accessible to more patients. This shift ...

Sun Pharma will launch generic semaglutide injection under the brand name, Noveltreat. Ganorkar added, "Noveltreat meets global quality standards and is supported by robust Indian clinical evidence on ...

Zydus Lifesciences is set to launch Semaglutide Injection in India upon patent expiry, bringing a novel, patient-friendly therapy for Type 2 Diabetes and Obesity. The drug features an adjustable, ...

In a recent video, Dr Madhu Chopra showcased a self-administered Botox procedure to combat facial drooping and explained how ...

Feb 25 - Zydus Lifesciences will launch generic versions of semaglutide injections for ‌obesity and diabetes in India after ‌patent expiry of the Ozempic active ingredient in late March, it said on ...

Weight loss injections have emerged as a notable alternative to traditional methods of losing weight. These types of injections are designed to support weight management by affecting the biological ...